News

Article

Envision Summit 2025: Importance of comanagement in glaucoma treatment

Key Takeaways

  • Co-managing glaucoma involves selecting therapeutics based on mechanism, efficacy, and tolerability, emphasizing strategic interventional therapies and surgical decisions.
  • Collaboration between optometrists and ophthalmologists is essential for effective glaucoma patient care.
SHOW MORE

At the Envision Summit 2025 in San Juan, Puerto Rico, Jessica Steen, OD, FAAO talked with glaucoma surgeons on the importance of comanaging patients throughout their lifetime.

Jessica Steen, OD, FAAO, Nova Southeastern University College of Optometry, discussed the importance of co-managing glaucoma patients throughout their lifetime – emphasizing the selection of therapeutics based on mechanism of action, efficacy, and tolerability, and the strategic use of interventional therapies and surgical decision-making. Steen highlighted the necessity of collaboration between optometrists and ophthalmologists for effective patient care. She also expressed excitement about new therapeutics in clinical trials, including those for neurodegeneration and neuroprotection, which extend beyond intraocular pressure (IOP) reduction.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.